Abelman RA, Fitzpatrick J, Zawedde J, Sanyu I, Byanyima P, Kaswabuli S, Musisi E, Hsieh J, Gardner K, Zhang M, Byanova KL, Sessolo A, Hunt PW, Lalitha R, Davis JL, Crothers K, Worodria W, Huang L. Sex modifies the risk of HIV-associated obstructive lung disease in Ugandans post-pneumonia. AIDS. [Epub ahead of print]. 2023 Jun 20. doi: 10.1097/QAD.0000000000003626. >> PubMed Citation
Chammas D. The stories we tell ourselves. JAMA. 2023 Jun 20;329(23):2019-2020. doi: 10.1001/jama.2023.8543. >> PubMed Citation
Dy M, Olazo K, Lisker S, Brown E, Saha A, Weinberg J, Sarkar U. Virtual reality for chronic pain management among historically marginalized populations: Systematic review of usability studies. J Med Internet Res. 2023 Jun 6;25:e40044. doi: 10.2196/40044. >> PubMed Citation
Kaltenbach T, Patel SG, Nguyen-Vu T, Malvar C, Keswani RN, Hall M, Aagaard E, Asokkumar R, Chin YK, Hammad H, Rastogi A, Shergill A, Simon V, Soetikno A, Soetikno R, Wani S. Varied trainee competence in cold snare polypectomy — results of the COMPLETE randomized controlled trial. Am J Gastroenterol. 2023 Jun 13. [Epub ahead of print]. doi: 10.14309/ajg.0000000000002368. >> PubMed Citation
Ko AH. Flashback foreword: KRAS is a selection marker for panitumumab benefit in patients with metastatic colorectal cancer. J Clin Oncol. 2023 Jun 20;41(18):3275-3276. doi: 10.1200/JCO.23.00221. >> PubMed Citation
|
Landovitz RJ, Scott H, Deeks SG. Prevention, treatment and cure of HIV infection. Nat Rev Microbiol. 2023 Jun 21. [Epub ahead of print]. doi: 10.1038/s41579-023-00914-1. >> PubMed Citation
Nguyen TTT, Lu W, Zhu WS, Ansel KM, Liang HE, Weiss A. Stimulation of ectopically expressed muscarinic receptors induces IFN-γ but suppresses IL-2 production by inhibiting activation of pAKT pathways in primary T cells. Proc Natl Acad Sci U S A. 2023 Jun 20;120(25):e2300987120. [Epub ahead of print]. doi: 10.1073/ pnas.2300987120. >> PubMed Citation
Schmid P, Cortes J, Joaquim A, Jañez NM, Morales S, Díaz-Redondo T, Blau S, Neven P, Lemieux J, García-Sáenz JÁ, Hart L, Biyukov T, Baktash N, Massey D, Burris HA 3rd, Rugo HS. XENERA-1: A randomised double-blind Phase II trial of xentuzumab in combination with everolimus and exemestane versus everolimus and exemestane in patients with hormone receptor-positive/HER2-negative metastatic breast cancer and non-visceral disease. Breast Cancer Res. 2023 Jun 12;25(1):67. doi: 10.1186/s13058-023-01649-w. >> PubMed Citation
Suliman S. BCG: From veins to correlates. Cell Host Microbe. 2023 Jun 14;31(6):921-923. doi: 10.1016/j.chom.2023.05.021. >> PubMed Citation
Tapper EB, Lai JC. Time to embrace PROMIS-29 as the standard health-related quality of life instrument for patients with cirrhosis. Hepatology. 2023 Jun 7. [Epub ahead of print]. doi: 10.1097/HEP.0000000000000508. >> PubMed Citation
|